Introduction
Brain-derived neurotrophic factor (BDNF) is a critical regulator of neural development, promoting the survival of a variety of neurons in the central nervous system (CNS) (for a review, see Angelucci et al. 1 ). For example, the development of certain phenotypic features of cortical GABA neurons requires BDNF. [2] [3] [4] [5] [6] In addition, BDNF is produced and released in an activity-dependent fashion by pyramidal neurons, a major target of GABA neurons. Together, these data suggest that BDNF is a target-derived trophic factor for GABA interneurons. In turn, GABA neurons might regulate BDNF synthesis and release from pyramidal cells in an activity-dependent manner. 7, 8 Cortical GABA neurons are heterogeneous and can be subdivided into a variety of subclasses based on their expression of different calcium binding proteins and neuropeptides (for a review, see Markram et al. 9 McBain and Fisahn 10 ). These subclasses also differ in their laminar distribution, connectivity and physiological properties. However, the dependence of different subclasses of GABA neurons on BDNF signaling remains to be determined. For example, the inducible deletion of BDNF 11 does not result in altered mRNA levels of the 67 kDa isoform of glutamic acid decarboxylase (GAD1) or parvalbumin (PARV) in adult mice. 12 Furthermore, the dependence of any given neuronal type on BDNF may differ as a function of developmental stage. 13 For example, BDNF is a critical mediator of the maturation of glutamatergic synapses in developing mouse somatosensory cortex. 14 Similarly, developing dorsal thalamus neurons need BDNF for survival from the cerebral cortex, and dorsal thalamic cell death can be regulated by increasing or blocking cortical levels of BDNF. 15 In addition, behavioral deficits are more pronounced in mice with embryonic than adult ablation of BDNF. 11 These data suggest that BDNF requirement of neurons may change from development to adulthood, and mice with embryonic and adult deletion of BDNF may exhibit markedly different neocortical transcriptome profiles.
To obtain comprehensive insight into the BDNFdependent transcriptome changes and determine what aspects of interneuronal phenotypes are affected by reduced BDNF levels, we performed high-density oligonucleotide microarray profiling of the prefrontal cortex of mice with inducible deletion of BDNF. The goals of the current study were to: (1) establish transcriptome changes which are a result of embryonic deletion of BDNF, (2) identify transcriptome changes that are a result of adult deletion of BDNF, (3) describe the genes that are most influenced by the absence of BDNF across both conditions, (4) define the transcriptome differences between the embryonic and adult BDNF-deficient mice, and (5) identify neuronal cortical phenotypes that may be preferentially affected by the absence of BDNF.
Materials and methods
Brain-derived neurotrophic factor -deficient mice All mice used in this experimental series were described previously. 11, 12 To generate the animals for the current experimental series, two geneticallyaltered, independently-derived mouse strains were used. Reduction of BDNF expression was achieved using an inducible knockout (KO) of the BDNF gene where two transgenes, the tetracycline transactivator (tTA) gene driven by neuron-specific enolase (NSE) promoter (nse-tTA) 16 and the Cre recombinase gene under the control of tTA-responsive tetO promoter (tetO-cre) 17, 18 regulate the deletion of floxed exon V of BNDF 19 in a tetracycline-dependent manner. The two mouse lines with NSE-tTA and tetO-cre transgenes were both maintained as homozygotes. Crossing of these lines resulted in bigenic mice. 19 For the embryonic deletion of BDNF, mice were bred in the absence of the tetracycline analogue doxycycline; this resulted in late embryonic ablation of BDNF. 16 For the adulthood deletion of BDNF, mice were bred in the presence of doxycycline (1 mg/ml) in drinking water and maintained on this until 3 months of age. At that time doxycycline was removed from the drinking water, thus inducing recombination. Maximum recombination was achieved 4 weeks after doxycycline removal 11 resulting in a > 70% reduction in BDNF transcript and protein levels. 11, 12 Littermates with NSE-tTA and tetO-cre transgenes were used as controls. These mice expressed similar levels of BDNF as wild type mice.
11
Mice with BDNF deletion induced from embryogenesis or in adulthood, together with the corresponding control animals, were sacrificed between 5 and 6 months of age. The experimental series consisted of frontal cortices from a total of 38 animals with different animals used for each method of gene expression analysis. For the microarray experiments, the adulthood and embryonic BDNF ablation groups consisted of four animals each, and these animals were compared to three control animals for each of the experimental groups (14 animals in total). For qPCR experiments, we used three animals for each experimental and control group (12 animals in total). For the in situ hybridization experiments, an additional three animals per group were assessed (12 animals in total).
Microarray experiments
Frontal cortices were rapidly dissected, frozen on dry ice, and stored at À801C until RNA extraction. Total RNA was isolated using the Trizol reagent. RNA quality was assessed using the Agilent Bioanalyzer. Reverse transcription, in vitro transcription and fragmentation were performed according to manufacturer's recommendation (Affymetrix, Sunnyvale, CA, USA). Samples were hybridized onto MOE430A mouse Affymetrix GeneChips which contained > 22 000 probesets using the Affymetrix hybridization station. To avoid microarray batch variation only microarrays from a single lot were used. Microarrays were considered for use only if the average 3 0 :5 0 ratio for GAPDH and actin did not exceed 1:1.2. Segmentation of scanned microarray images was performed by Microarray Analysis Suite 5.0 (MAS5). Determination of expression levels and scaling were performed using Robust Multi-array Average (RMA). 20, 21 The resulting data set was filtered for genes that reported < 30% present calls based on MAS5 analysis. For scale linearity, the data were log2 transformed, and differential expression was established using average log2 ratio (ALR) between the studied cohorts (|ALR| = 1 corresponds to a twofold increase or decrease, |ALR| = 0.585 represents a 50% change, while |ALR| = 0.263 depicts a 20% expression alteration).
Data analysis
Identification of differentially expressed genes across mice with adult and embryonic BDNF-deletion: We identified genes as differentially expressed between all wild-type and all BDNF KO samples if they fulfilled the following four criteria: (1) reported > 0.263 |average log 2 ratio| (|ALR|) in embryonic BDNF-deleted mice versus their matched wild-type controls, (2) a group-wise Student's t-test reported P < 0.05 in the embryonic BDNF-deleted mice versus their matched wild-type controls, (3) reported > 0.263 |ALR| in adult BDNF-deleted mice versus their matched wild-type controls and (4) a group-wise Student's t-test reported P < 0.05 in the adult BDNFdeleted mice versus their matched wild-type controls. These combined criteria were implemented to reduce false positive findings and eliminate significant, but very small, expression changes that may have a marginal biological effect. 22 A gene was 'definitively changed' if it met all four aforementioned criteria, while a gene was considered 'putatively changed' if it met three of these four criteria.
Identification of differentially expressed genes showing a more robust expression change in mice with embryonic BDNF-deletion: A gene was considered to show a more robust expression change in the comparison of mice with embryonic BDNF deletion and matching wild-type controls if it reported: (1) an |ALR| difference > 0.263 between the two BDNF-deleted mouse groups versus their own controls (ALR DIF = ALR ADULT KOÀWT -ALR EMBRYONIC KOÀWT ) and (2) Student's t-test significance for the embryonic BDNF-ablated mice at P < 0.05 level in comparison to the control littermates.
Estimation of false discovery ratio: Estimation of false discovery ratio (FDR) was performed for the genes that were commonly altered between the mice with embryonic and adult deletion of BDNF using a custom-designed permutation-based method. [23] [24] [25] Briefly, microarrays were randomly mixed into two groups containing near equal numbers of experimental and control arrays (see Supplementary Figure 1 ). Six random permutations were performed with a blocking factor of mouse type (e.g., embryonic or adult deletion). For each permutation the two array groups were subjected to the same analysis that was used to determine the expression differences (see above). The discovered genes (false positive discovery) were averaged across the six comparisons and this value was expressed as a percentage of genes uncovered in the true experimental comparison, thus representing FDR in our experimental design.
Calculation of pooled significance: As we used independent samples with independent controls across the two groups of BDNF-ablated mice, expression levels were compared independently. Combined significance in all tables was achieved by calculating the À2 Â (ln (P-value embryonic BDNF KO comparison) þ ln(P-value for adult BDNF KO comparison)). The calculation was performed with four degrees of freedom.
Correlations: Correlations were calculated using Pearson r-value for the log 2 ratios between the two compared conditions.
Clustering: Two-way clustering (sample and gene vectors) was performed on RMA generated log2-transformed expression levels using Euclidian distance measurement in Genes @ Work developed by IBM. 26 Custom database: Robust multi-array average normalized data and statistical measurements were imported into MS-Access. This database is searchable by significance, accession number, log ratio and gene name. The database displays individual RMA normalized data points across all experimental conditions. Data sharing: The MS-Access database with all data points (B130 MB) is available upon request. All the raw microarray data has been deposited into GEO in a MIAME-MGED compliant format and is publicly available without any restrictions.
Transcript quantification by real-time quantitative polymerase chain reaction For selected genes quantitative polymerase chain reaction (qPCR) was performed on a new set of animals from each group (three each for both experimental and control groups, 12 in total). Validation was performed on all samples, each originating from a single animal. After primer validation (primer efficiency 95-100%) the experiments were performed using standard delta Ct-Sybr Green measurement protocols with two independent reverse transcriptions and four replicates for each of the reverse transcriptions. 27 Beta-actin was used as a standard normalizer. Statistical significance was calculated using a Student's t-test using DC t measurements for each well. DDC t was calculated as (average DC t experimental) -(average DC t control) between the tested groups. All primer sequences are available upon request.
In situ hybridization Coronal sections of 20-mm thickness were cut from tissues containing the frontal cortex using a cryostat at À201C, mounted on to gelatin-coated glass slides and stored at À801C until use. cRNA [ 35 S]-labeled riboprobes were generated by PCR amplification of cDNA obtained from normal mouse brain. Approximately 3 ng (B2 Â 10 6 DPM) of labeled probe was hybridized per each section. Methods used for hybridization were described previously. 28, 29 Slides were exposed to BioMax MR film (Kodak, Rochester, NY, USA) for 8-22 h and then dipped and exposed to autoradiographic emulsion (NTB-2, Kodak) for 3-5 days at 41C. Scion Image (version 4.0b) was used to obtain high-resolution scans of each film image for quantification. Dark-field images were captured from the developed slides. Slides were coded as to render the investigator performing the analysis blind to the condition of each specimen. Knockout and control sections were processed in parallel. Control hybridization with sense probe did not result in detectable signal.
Quantification was performed by subtracting the average white matter optical density (OD) from the average signal measured across the neocortex (Scion Image, Scion Corporation, Frederick, MD, USA). Relative expression differences were determined as a mean background-corrected OD differences of three animals per group, and significance was determined by Student's t-test.
Results
Transcriptome changes of mice with conditional ablation of BDNF during adult and embryonic life: similarities in expression patterns Transcriptome analysis of BDNF-ablated mice at embryonic and adult age revealed a number of similarities. When compared to their respective control animals, 31 gene probesets reported significantly changed expression in both groups of BDNFdeficient mice (RMA measured |ALR| > 0.263 and P < 0.05 in both groups of mice; Table 1 ). None of these probesets reported expression changes that were opposite in direction across the two BDNF KO groups. These expression data were part of a data set with a low false discovery ratio (FDR < 2%, Supplementary Figure 1 ). Of the genes with changed expression across both groups of mice, reductions in gene expression were more commonly observed than A differentially expressed gene had to show an |ALR| > 0.263 and a significance of P > 0.05 in both the embryonic and adult BDNF-ablated comparisons. Thirty-one gene probesets fulfilled these criteria. (Probeset -Affymetrix GeneChip identifier; ExpAD and ExpEM -RMA log2 expression level of adult and embryonic BDNFdeficient animals; CoAD and CoEM-RMA log2 expression level of corresponding control wild-type animals; ALR-average log2 ratio for the adult and embryonic BDNF-deficient comparisons; pval -Student's T-test P-value; Comp pval -P-value calculated across the two comparisons using Chi distribution).
transcript inductions (24 probesets with a mean ALR = À0.59 and 7 probesets with a mean ALR = 0.39, respectively). In a two-way hierarchical clustering (Figure 1 ), both BDNF-deficient groups showed a clear separation of experimental and control animals, suggesting that this robust pattern is a clear consequence of BDNF deficiency. The expression ratios of the adult and embryonic BDNFablated mice versus their own controls showed a remarkable correlation for this set of genes (r = 0.96, P < 0.001; see Figure 2a for details).
We also identified a set of genes that showed a putative expression change across the two BDNFablated mouse groups (Table 2) . When compared to their own controls, these genes showed a significant expression change for at least three of the four statistical criteria used in this study (ALR > 0.263 and P < 0.05 in both groups). Based on the following arguments, the majority of these 46 transcripts are very likely to represent true biological expression differences: (1) The FDR for this group was B16% (Supplementary Figure 1) ; (2) This group contained several duplicate microarray probe sets against genes that already reported a definitive expression change in Table 1 ; (3) Clustering with these genes perfectly separated out the KO and the WT animals in both the adult and embryonic BDNF ablation (Supplementary Figure 2) ; (4) For these genes, the expression levels between the two groups of BDNF-ablated mice were highly correlated (r = 0.92; Figure 2B ). (5) Selected transcript changes from this group were successfully verified by qPCR (see below). Figure 1 Two-way clustering of the normalized expression levels for 31 genes showing common expression changes in adult and embryonic brain-derived neurotrophic factor (BDNF)-ablated mice. In the vertical dendrogram each arm represents a single animal (red-cKO; black -wild-type control), rows denote gene probesets with NCBI accession numbers and gene symbols. Each pixel denotes a log2-normalized expression level in a single animal. Intensity of red is proportional to transcript increase, green intensity is proportional to transcript decrease. Dark boxes represent unchanged expression. Based on the expression levels of these 31 genes, the vertical dendrogram perfectly separated out the mouse genotypes both in the adult (left panel) and embryonic BDNF comparisons (right panel). Note that the clustering gave rise to an identical pattern in the two groups of the BDNF-deficient animals. For gene names and statistical parameters, see Table 1 .
Not surprisingly, the gene with the most reduced expression level was BDNF in both the adult and embryonic BDNF-ablated mice (ALR = À1.18 with P = 0.0042 and ALR = À1.20 with P < 0.0006, respectively), which further validates our findings and is consistent with previously published finding that these mice have a > 70% expression deficit in BDNF expression. 11, 12 The observed expression changes also involved three independent probesets of cyclin D2 (CCND2), as well as genes that interact with CCND2 (cyclin-dependent kinase inhibitor 1C -CDKn1c and Ca/CaM-dependent protein kinase I gammaCAMK1g). Furthermore, the levels of the early immediate genes (IEG) activity regulated cytoskeletal-associated protein (ARC), early growth response 1 (EGR1), early growth response 2 (EGR2), FBJ osteosarcoma oncogene (FOS), dual specificity phosphatase 1 (DUSP1) and dual specificity phosphatase 6 (DUSP6) were also robustly altered, suggesting that BDNF levels are critical for regulation of a complex IEG-dependent transcription network.
Furthermore, regulator of G-protein signaling 4 (RGS4) transcript was significantly decreased in the cortex of mice with the adulthood deletion of BDNF (ALR = À0.35; P = 0.0046). A similar trend was observed in the mice with embryonic BDNF deletion (ALR = À0.35; P = 0.0638), suggesting a causal relationship between BDNF expression and RGS4 transcript levels.
Somatostatin (SST), neuropeptide Y (NPY) and tachykinin 1 (TAC1) are all interneuronal peptide transcripts which are coexpressed to a large degree and define a subset of GABA-containing neocortical interneurons. [30] [31] [32] All three transcripts were downregulated in both mice with embryonic (SST: ALR = À0.41; P = 0.0279; NPY: ALR = À0.38; P = 0.0348; TAC1: ALR = À0.31; P = 0.0525) and adulthood (SST: ALR = À0.49; P = 0.0054; NPY: ALR = À0.39; P = 0.0254; TAC1: ALR = À0.86; P = 0.0392) deletion of BDNF.
Transcriptome changes of mice with conditional ablation of BDNF during adult and embryonic life: differences in expression patterns In addition to gene expression changes that were shared between the embryonic and adult KO animals, we also observed a number of gene expression changes that were specific to one of the BDNF-ablated groups. For the listing of all differentially expressed genes, see Supplementary Tables 1 and 2 . From all these changes, one group of genes attracted our attention in particular. Namely, as the embryonic BDNF deletion creates a behavioral phenotype not observed in the adult BDNF-deficient animals, 11 we hypothesized that the embryonic BDNF-deficient mice would show an expression phenotype not present in the adult KO animals. To identify this putative gene expression phenotype, we defined a set of genes that showed significant expression differences in the comparison of embryonic BDNF KO and control animals, but which were not observed (or not observed to the same degree) in the comparison of the adult BDNF KO mice and their matching wild-type controls (Table 3) . Only 31 gene probesets matched these criteria. Of these expression changes, 11 were more upregulated in the embryonic comparison vis-à-vis the adult comparison, while 20 genes were more downregulated. Gene expression differences included alterations in critical developmental genes (HOMER1, neurogenic differentiation 6-NEUROD6/MATH2, neuronal pentraxin 2-NPTX2 and growth arrest specific 5-GAS5), RAN-RAP system genes (RAN GTPase activating protein 1-RANGAP1, RAN binding protein 2-RANBP2, RAP1 GTP-GDP dissociation stimulator 1-RAPGDS1) and a variety of other functional classes. Interestingly, the two most upregulated gene probes encoded the same gene, D7RP2e (DNA segment, Chr 7, Roswell Park 2 complex), a gene with uncharacterized function. These 31 genes, using a two-way hierarchical clustering, separated correctly the ani- Figure 2 Correlation of expression changes between the adult and Embryonic brain-derived neurotrophic factor (BDNF)-deficient animals. X axis represents the average log2 ratio (ALR) in the adult BDNF-ablated -wild type comparison, while the Y axis represents the ALR in the embryonic BDNF-deficient -wild-type comparison. Each symbol represents a single gene. Both the definitively changed genes (a) and putatively changed genes (b) showed a very high correlation across the two models (r = 0.96, P < 0.001 and r = 0.92, P < 0.001, respectively). For ALR rations and other data see Tables 1 and 2 . (Figure 3, left panel) . However, the same genes could not distinguish between the adult BDNF-ablated animals and their control littermates ( Figure 3 , right panel).
Validation of microarray findings
All of the 10 expression changes (SST, NPY, ARC, CCND2, EGR1, RGS4, CAMK1g, DUSP6, amyloid beta precursor protein-binding A1 -APBA2bp, Kv channel-interacting protein 2 -KCNIP2 and BDNF) tested were successfully verified by RT-qPCR on a new set of control and BDNF-ablated animals ( Figure 4 ). When the microarray-reported groupwise ALR values were compared to the groupwise qPCR ÀDDC t values for the 10 genes, the microarray and qPCR data sets showed a high concordance in both the embryonic and adult BDNF-ablated animals (r = 0.88, P < 0.001 and r = 0.83, P < 0.001, respectively). The magnitudes of observed expression changes were more prominent in the qPCR experiment than those reported by the GeneChips, confirming previous reports that RMA analysis may underestimate the expression differences in microarray experiments. 20, 24 BDNF is required for maintenance of SST-NPY interneuronal phenotype in the frontal cortex Brain-derived neurotrophic factor is believed to be critical for the development of cortical interneurons, 4, 6, [33] [34] [35] but the specificity of BDNF action for specific subclasses of interneurons is not known. Our previously published study suggested that the PARV containing interneuronal class is not affected in either one of these BDNF-ablated mice and that the overall GABA-ergic phenotype of the interneurons, judged by presence of GAD1 transcript levels, is preserved. 12 However, both the microarray and qPCR data sets strongly suggested that BDNF expression has a critical effect on SST, NPY and TAC1-containing interneuronal populations. In addition, in situ hybridization ( Figure 5 ) revealed a robust and significant downregulation of SST in the neocortex of both the adult and embryonic BDNF-ablated mice (1.7 and 1.9-fold, respectively) in another cohort of mice. Because SST, NPY and TAC1 are co-expressed to a large extent in a subset of GABA-ergic cortical cells, [30] [31] [32] [36] [37] [38] [39] we suggest that these transcripts are downregulated in the same interneuronal sub-population and most likely represent an interlinked, BDNF-dependent pathology.
Discussion
In this study, we analyzed neocortical transcriptome changes in response to embryonic and adult conditional ablation of BDNF. This study revealed that: (1) the transcriptomes of the adult and embryonic BDNFdeficient mice show highly correlated similarities, including altered expression of the transcripts encoding neuropeptides (SST, NPY, TAC1), early-immediate genes (ARC, EGR1, EGR2, FOS, DUSP1, DUSP6) and critical cellular signaling systems (CDKN1c, CCND2, CAMK1g, RGS4); (2) the embryonic BDNF KO animals, when compared to the adult BDNF KO mice, reported significant expression changes in several genes related to neuronal differentiation (GAS5, NPTX2, NEUROD6, HOMER1), GTPase activating systems (RAP1GDS1, RAN2BP2, RANGAP1) and multiple other genes; and (3) BDNF appears to be critical for maintaining SST-NPY-TAC1 expression in interneurons in both embryonic and adult KO mice, but without altered expression of GAD1, GAD2, calretinin-CALR or PARV.
Transcriptome similarities between the embryonic and adult BDNF-deficient mice Deletion of the BDNF gene in embryonic and adult BDNF-deficient mice is primarily characterized by transcript decreases. In the context of the physiological role of BDNF, this apparent 'loss of function' is expected; increased BDNF is associated with activity, 40 ,41 cell survival, [42] [43] [44] learning and memory, 45 synaptic plasticity, 46, 47 increased synthesis of mRNA and other processes that can be looked upon as 'positive' cellular events. Loss of BDNF would therefore be expected to decrease the expression of genes that mediate these effects. The genes with altered transcription implicate the following processes that are likely to be altered in these mice.
First, a number of the IEGs (ARC, EGR1, EGR2, FOS, DUSP1, DUSP6) showed robust decreases in both adult and embryonic KO animals. In contrast, upregulation of BDNF by exercise 25, 40, 41 or by other in vitro manipulations leads to induction of these genes. 48 IEG induction is known to be strongly regulated via the MEK-ERK pathway, 49, 50 which is also one of the main effectors of BDNF signaling. 51, 52 Hence, we propose that the IEG transcript downregulations we see in the BDNF-deficient animals are due to the lack of release of BDNF and impaired trophic support. 53, 54 Second, the cyclin-dependent kinase inhibitor 1C (CDKN1c) and cyclin D2 (CCND2) also showed Figure 3 Expression changes specific for mice with the embryonic deletion of brain-derived neurotrophic factor (BDNF). A clustering of the 31 identified gene probes was performed and is presented similar to that seen in Figure 1 . For source data and abbreviations see Table 3 . Note that the wild-type and BDNF-ablated mice separate according to genotype (vertical dendrogram) in the mice with the embryonic deletion of BDNF (left panel), but not in mice with adult deletion of BDNF (right panel). Some of these expression changes may be responsible for behavioral differences between the two BDNF-deleted groups of mice. Layout is similar to Table 1 with an addition of a last column (dALR) that describes the ALR difference seen between the embryonic and adult comparisons. Genes marked with * represent developmental genes while ** denotes RAN-RAP system genes.
expression changes in both groups of KO animals. CDKN1c has been shown to be an inhibitor of the CCND2/CDK complexes, 55 and consistent with this functional interaction, CDKN1c is the most upregulated gene product in the BDNF-deficient mice, while CCND2 is one of the genes showing the most robust transcript decreases. In addition, a strong functional relationship exists between cyclins and Ca/CAM kinase activity, 56 suggesting that the observed CDKN1c, CCND2 and CAMK2g transcript alterations are causally related. Recent evidence suggests that CCND2 is important in development for neurogenesis, proliferation and differentiation, 57, 58 and may be involved in promotion of GABA-ergic phenotype. 59, 60 As CCND2 is under the control of the previously discussed IEGs, we believe that the CDKN1c, CCND2 and CAMK2g transcript changes are mediated via the BDNF-MEK/ERK-IEG pathway.
Expression differences between the embryonic and adult BDNF deficient mice Beyond common transcriptome alterations, mice with embryonic and adult deletion of BDNF also showed several significant gene expression differences. Most notably, the embryonic BDNF KO animals, when compared to the adult BDNF KO mice, reported significant expression changes in several genes related to neuronal differentiation (GAS5, NPTX2, NEUROD6, HOMER1) and GTPase activating systems (RAP1GDS1, RAN2BP2, RANGAP1). As alterations in either of these systems may lead to altered behavior, [61] [62] [63] we propose that some of the observed transcriptome changes, in the frontal cortex or other brain regions, are the underlying cause of the behavioral changes in the mice with conditional ablation of BDNF.
Effect of BDNF on interneuronal gene expression phenotype As our microarray experiments were performed on bulk cortical tissue, the expression changes we observed in the absence of BDNF reflect a sum of transcriptome changes that may occur in a number of different cell types. In the context of the phenotypic diversity of the neocortex, the transcriptome of projection neurons, glial cells and interneurons could be differentially affected by BDNF ablation. To overcome this limitation of the microarray technology, we decided to focus our primary attention to expression changes related to specific markers of neuronal Figure 4 Real-time qPCR and GeneChip microarray data are highly correlated. 10 genes were chosen for further verification based on their biological significance on new cohorts of brain-derived neurotrophic factor (BDNF)-deficient and control mice. The statistical data obtained with the two methods showed a high degree of similarity (a). The qPCR -microarray correlation was very high in both the animals with adult (b) and embryonic (c) BDNF deletion (r = 0.88, P < 0.001 and r = 0.83, P < 0.001, respectively).
subpopulations that show a well-defined neocortical distribution.
PV, CCK and SST are expressed in separate classes of cortical interneurons. [64] [65] [66] [67] [68] In interneurons SST, NPY and TAC1 are co-expressed to a great extent and SST/NPY expression can be induced by a BDNF/ TrkB-dependent mechanism.
69-71 While we observed a strong downregulation in the SST-NPY-TAC1 transcripts in both adult and embryonic BDNF-ablated mice, we found the expression of other GABA colocalizing neuropeptides and GABA-production enzymes unchanged. These data are in agreement with our recent findings that PV and GAD1 expression are not directly BDNF-dependent. 12 Rather, GAD1 and PV expression depend on the expression of a functional TrkB receptor: TrkB-deficient mice show a remarkable downregulation in GAD1 and PV transcripts, which is not observed in the BDNF-deficient animals. These data, combined with the SST-NPY-TAC1 expression reduction in the BDNF-deleted mice, argue that interneuronal gene expression is regulated in a complex manner (Figure 6 ). While PV expression may be co-regulated with GAD1, the SST-NPY-TAC1 phenotype appears to be GAD1-independent. This suggests that BDNF may influence different subclasses of interneurons through different molecular mechanisms: the PV-GAD1 regulation is achieved through the TrkB receptor, while the maintenance of SST-NPY-TAC1 interneuronal phenotype may depend on both BDNF and TrkB expression.
BDNF regulation of the transcriptome: relevance to human brain disorders Multiple lines of evidence imply that the BDNF gene is involved in the pathophysiology of schizophrenia. Although population studies have yielded divergent data about the association of variants in the BDNF gene with increased risk and developmental features of schizophrenia, [72] [73] [74] [75] [76] [77] [78] human postmortem studies suggest that individuals with schizophrenia have reduced expression of TrkB and BDNF in the cerebral cortex, 12, [79] [80] [81] [82] as well as decreased BDNF protein levels in the serum. 83 In addition, various animal models of schizophrenia consistently show a downregulation of BDNF transcript or protein. 4, [75] [76] [77] [78] [84] [85] [86] [87] [88] Importantly, just as in our current study of BDNF- ablated animals, SST, NPY and RGS4 transcripts are downregulated in the prefrontal cortex (PFC) of subjects with schizophrenia. 29, 89, 90 However, we acknowledge that other, BDNF-independent mechanisms may also account for the altered expression of these genes in schizophrenia. 91, 92 The extent to which a BDNF-dependent transcriptome profile is present in schizophrenia remains to be established in hypothesis-driven assessment of gene expression changes in the human PFC.
Our findings are also important in the context of recent research on Alzheimer's disease (AD)-related pathology. Existing evidence suggests that BDNFTrkB controlled SST-NPY levels may play a critical role in the progression of AD. First, SST-NPY containing interneurons have been implicated in learning and memory [93] [94] [95] [96] and post-mortem brain studies of AD repeatedly observed a severe loss of SST immunoreactive neurons and axons. 31, 95, [97] [98] [99] [100] In addition, APPswe/PS1dE9 amyloid plaque producing mice show reduced SST levels in the cortex, 101 and this is likely mediated through the interference of amyloid-beta (Ab) with the BDNF-induced activation of the Ras-mitogen-activated protein kinase/extracellular signal-regulated protein kinase (ERK) and phosphatidylinositol 3-kinase (PI3-K)/Akt pathways. 102 In contrast, it appears that inducing increased expression of SST may be beneficial for patients suffering from AD: compounds increasing SST expression are in phase II clinical trials as cognition enhancing agents (FK962, Astellas Pharma, Tokyo, Japan), 103 and transgenic models of amyloid deposition are reversed by environmental enrichment, 25 which is known to induce SST-NPY expression via a BDNF-dependent pathway. Thus, while altered BDNF expression may not represent the primary disturbance in AD, changed expression of, or altered responsiveness to BDNF (and subsequently decreased SST levels) may represent a critical feature of Alzheimer's disease progression. Figure 6 Brain-derived neurotrophic factor (BDNF) regulation of interneuronal transcripts. In wild-type animals BDNFTrkB signaling is required for maintenance of early immediate genes (IEG), glutamic acid decarboxylase (GAD67), PV, Somatostatin (SST), neuropeptide Y (NPY) and tachykinin 1 (TAC1) expression. Reduction in TrkB, but not BDNF is sufficient to downregulate GAD67 and PV expression. However, BDNF appears to be required for maintenance of the SST-NPY-TAC1 interneuronal neuropeptides.
